(Q37576090)

1 July 2019

review article

1 reference

title

An update on treatment and prevention strategies for Alzheimer's disease (English)

1 reference

1 July 2019

0 references

2

Mary Sano

1 reference

1 July 2019

author name string

Judith Neugroschl

series ordinal

1

1 reference

1 July 2019

publication date

1 September 2009

1 reference

1 July 2019

Current Neurology and Neuroscience Reports

published in

1 reference

1 July 2019

volume

9

1 reference

1 July 2019

issue

5

1 reference

1 July 2019

page(s)

368-376

1 reference

1 July 2019

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

The Women's Health Initiative Memory Study: findings and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0054-1

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

21 January 2018

1 reference

12 December 2020

Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease.

1 reference

12 December 2020

Mitochondria as a target for neurotoxins and neuroprotective agents

1 reference

12 December 2020

Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease

1 reference

12 December 2020

Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease

1 reference

12 December 2020

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

1 reference

12 December 2020

Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels

1 reference

12 December 2020

Neuropathological diagnostic criteria for Alzheimer's disease.

1 reference

12 December 2020

Ginkgo biloba for prevention of dementia: a randomized controlled trial

1 reference

12 December 2020

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

1 reference

12 December 2020

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

1 reference

12 December 2020

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial

1 reference

12 December 2020

Cerebral hemorrhage after passive anti-Abeta immunotherapy

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

The inflammatory hypothesis of Alzheimer disease: dead or alive?

1 reference

12 December 2020

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

12 December 2020

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

12 December 2020

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers

1 reference

12 December 2020

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

1 reference

12 December 2020

Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial

1 reference

12 December 2020

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Tangles precede plaques but don't cause them

1 reference

12 December 2020

Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons

1 reference

12 December 2020

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

1 reference

12 December 2020

Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial

1 reference

12 December 2020

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

12 December 2020

Dimebon improves learning in animals with experimental Alzheimer's disease

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis

1 reference

12 December 2020

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

12 December 2020

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

12 December 2020

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

12 December 2020

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

1 reference

12 December 2020

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

1 reference

12 December 2020

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

1 reference

12 December 2020

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.

1 reference

12 December 2020

Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

12 December 2020

Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial

1 reference

12 December 2020

A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study

1 reference

12 December 2020

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

12 December 2020

A novel immunotherapy for Alzheimer's disease: antibodies against the beta-secretase cleavage site of APP.

1 reference

12 December 2020

Long-term effects of cognitive training on everyday functional outcomes in older adults

1 reference

12 December 2020

{beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents.

1 reference

12 December 2020

Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease

1 reference

12 December 2020

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

12 December 2020

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

1 reference

12 December 2020

Tau protein abnormalities associated with the progression of alzheimer disease type dementia

1 reference

12 December 2020

Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways

1 reference

12 December 2020

Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100.

1 reference

12 December 2020

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

1 reference

12 December 2020

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

12 December 2020

Therapeutic strategies for Alzheimer's disease

1 reference

12 December 2020

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein

1 reference

12 December 2020

10.1007/S11910-009-0054-1

Identifiers

DOI

1 reference

1 July 2019

PMC publication ID

6485240

1 reference

1 July 2019

PubMed publication ID

19664366

1 reference

1 July 2019